Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2015-05-14 Director's Dealing
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2015-05-14 English
FORM 4
Director's Dealing
2015-05-14 English
Interim / Quarterly Report 2015
Interim / Quarterly Report Q1 2015
2015-05-08 English
Earnings Release 2015
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 7, 2015. It announces the company's financial and operating results for the period ended March 31, 2015, and includes a press release as an exhibit. The text does not contain the actual financial statements or detailed financial data but rather refers to the press release attached. The document length is 2357 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document announcing results with an attached press release is classified as an Earnings Release (ER).
2015-05-07 English
Regulatory Filings 2015
Regulatory Filings
2015-04-30 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text mentions an announcement of resuming manufacturing operations and preliminary financial results for Q1 2015, but it does not contain detailed financial statements or comprehensive financial analysis. The document is short (2833 characters) and includes a press release as an exhibit. It is not a full quarterly or annual report but rather a current report announcing operational and preliminary financial updates. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories and includes Form 8-K filings.
2015-04-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.